We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 10, 2019

SCT From a Haploidentical Donor vs a Genoidentical Sister for Adult Male Patients With AML in First Remission

Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer
Stem Cell Transplantation From a Haploidentical Donor Versus a Genoidentical Sister for Adult Male Patients With Acute Myelogenous Leukemia in First Remission: A Retrospective Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Cancer 2019 Nov 27;[EPub Ahead of Print], NC Gorin, M Labopin, D Blaise, M de Groot, G Socié, JH Bourhis, F Ciceri, E Polge, A Nagler, M Mohty

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading